*0011034050
*00520190130100722.0
*007ta
*008130408s2004    xx#           000 u eng d
*00901177caa a2200289 c 4500
*019  $bk
*035  $a(EXLNZ-47BIBSYS_NETWORK)990517811744702201
*035  $a(NO-TrBIB)051781174
*035  $a051781174-47bibsys_network
*040  $aNO-TrBIB$bnob$ekatreg
*24500$aTreatment with pegylated interferon and ribavarin in HCV infection with genotype 2 or 3 for 14 weeks :$ba pilot study$cO. Dalgard...[et al.]
*260  $c2004
*300  $aS. 1260-5
*500  $aØvrige forfattere: K. Bjøro, K.B. Hellum, B. Myrvang, S. Ritland, K. Skaug, N. Raknerud, H. Bell
*653  $aaker$auniversitetssykehus$_87030900
*7001 $aBell, Helge$d1946-2004$0(NO-TrBIB)90183917$_79476400
*7001 $aBjøro, Kristian$0(NO-TrBIB)1029805$_110333200
*7001 $aDalgard, Olav$d1961-$0(NO-TrBIB)90061647$_66710100
*7001 $aHellum, K.B.$0(NO-TrBIB)4072684$_125774900
*7001 $aMyrvang, Bjørn,$d1940-$0(NO-TrBIB)90120048$_73827300
*7001 $aRaknerud, N.$0(NO-TrBIB)1024020$_125667600
*7001 $aRitland, S.$0(NO-TrBIB)3067974$_114374800
*7001 $aSkaug, K.$0(NO-TrBIB)1028015$_125423100
*7730 $tHepatology (trykt utg.).$dNew York : Wiley$g40(2004)6$x0270-9139$w999303747114702201$w(NO-LaBS)84945(tnr)
*901  $a80
*999  $aoai:nb.bibsys.no:990517811744702202$b2021-11-01T03:18:01Z$z990517811744702202
^